Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours (British Journal of Cancer, (2021), 10.1038/s41416-021-01632-2)

Jason D. Lickliter, Mark Voskoboynik, Linda Mileshkin, Hui K. Gan, Ganessan Kichenadasse, Kathy Zhang, Maggie Zhang, Zhiyu Tang, Michael Millward

Research output: Contribution to journal › Comment/debate

41 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours (British Journal of Cancer, (2021), 10.1038/s41416-021-01632-2)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science